SANRENO THERAPEUTICS
SanReno Therapeutics develop, manufacture and commercialize kidney disease therapies in the People’s Republic of China, Hong Kong, Macau, Taiwan and Singapore (the “Territory”). SanReno Therapeutics formed with JV of Chinook Therapeutics and Frazier Healthcare Partners and Pivotal bioVenture Partners China.
SANRENO THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2020-01-01
Address:
Beijing, Beijing, China
Country:
China
Status:
Active
Total Funding:
40 M USD
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Funding Round - SanReno Therapeutics
Pivotal bioVenture Partners
Pivotal bioVenture Partners investment in Funding Round - SanReno Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Funding Round - SanReno Therapeutics
Versant Ventures
Versant Ventures investment in Funding Round - SanReno Therapeutics
More informations about "SanReno Therapeutics"
SanReno Therapeutics Announces Acquisition by Novartis in …
Jan 5, 2024 SanReno Therapeutics is a leading clinical-stage enterprise specializing in the …See details»
SanReno Therapeutics - VentureRadar
" SanReno Therapeutics is a joint venture between Chinook Therapeutics and an investor …See details»
SanReno Therapeutics 2025 Company Profile: …
SanReno Therapeutics General Information Description. Developer of biotech therapies focused on kidney diseases and related therapeutic areas. The …See details»
Chinook Therapeutics Announces Formation of SanReno
Nov 30, 2021 SanReno will be responsible for all development, manufacturing and …See details»
SanReno Therapeutics (Shanghai)Co.,Ltd (信瑞诺医药（上海）有限 …
About SanReno Therapeutics (Shanghai)SanReno Therapeutics (Shanghai) Co., Ltd is a …See details»
Novartis acquires SanReno Therapeutics | Biotech Sphere
Jan 8, 2024 SanReno Therapeutics, established in late 2021 as a joint venture between an investor consortium and Chinook Therapeutics (now part of Novartis), has been at the forefront of developing transformative medicines for kidney …See details»
Novartis buys Singapore company developing IgA nephropathy …
Jan 9, 2024 Novartis has agreed to buy SanReno Therapeutics, a clinical-stage company that …See details»
Novartis Buys Chinese Kidney Disease Specialist …
(Yicai) Jan. 8 -- Swiss pharmaceutical giant Novartis said it has inked a deal to acquire SanReno Therapeutics, a Chinese biotechnology firm that specializes in developing renal disease treatments. SanReno will be merged into Novartis …See details»
Exploring the Latest ETA Antagonists Deal by SanReno …
Jan 5, 2024 About SanReno Therapeutics (Shanghai) SanReno Therapeutics (Shanghai) Co., Ltd is a biomedicine organization founded in 2021, with a focus on developing therapeutics for various therapeutic areas. The company has a …See details»
Novartis Buys Chinese SanReno - BRICS Competition
Jan 10, 2024 SanReno is a joint venture of Seattle-based Chinook and several life sciences …See details»
SanReno Therapeutics announces acquisition by …
Jan 11, 2024 SanReno Therapeutics has announced that it has been acquired by Novartis, becoming an indirect, wholly-owned subsidiary of Novartis. The investors that helped found SanReno—including Pivotal bioVenture Partners …See details»
SanReno Therapeutics Announces Acquisition by Novartis in …
Jan 5, 2024 About SanReno Therapeutics SanReno Therapeutics is a leading clinical-stage …See details»
SanReno Therapeutics(Shanghai)Co.,Ltd - Drug pipelines, Patents ...
About SanReno Therapeutics (Shanghai)SanReno Therapeutics (Shanghai) Co., Ltd is a …See details»
SanReno Therapeutics - VentureRadar
SanReno Therapeutics is a joint venture between Chinook Therapeutics and an investor …See details»
SanReno Therapeutics - Funding, Financials, Valuation & Investors
SanReno Therapeutics develop, manufacture and commercialize kidney disease therapies. …See details»
SEC.gov | HOME
SanReno Therapeutics. In November 2021, we entered into the China License Agreement, …See details»
Chinook Therapeutics Announces Formation of SanReno …
Nov 30, 2021 SEATTLE , WA – Chinook Therapeutics, Inc. (Nasdaq: KDNY), a …See details»
sanreno.com
Sanreno.comSee details»
New study results reinforce Tagrisso as the backbone therapy for …
Mar 25, 2025 New study results presented at the European Lung Cancer Congress (ELCC) …See details»
SanReno Therapeutics Announces Acquisition by Novartis in …
Jan 9, 2024 SanReno Therapeutics, a clinical-stage company specializing in the discovery, …See details»